Lv1
38 积分 2022-07-15 加入
Treatment and survival outcomes for patients with follicular lymphoma and POD24: a systematic review and meta-analysis
21天前
已完结
Treatment of relapsed and refractory follicular lymphoma: which treatment for which patient for which line of therapy?
21天前
已完结
Clinical characteristics and outcomes of follicular lymphoma patients with extranodal involvement: analysis of a series of 1090 cases in China
1个月前
已完结
Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial
3个月前
已完结
Infusion-related reactions to rituximab: frequency, mechanisms and predictors
3个月前
已完结
Inebilizumab for Treatment of IgG4-Related Disease
5个月前
已完结
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
7个月前
已完结
A New Era in the Treatment of Myasthenia Gravis: Six New Medications in The Last 6 Years
7个月前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
8个月前
已完结
皖公网安备34019202002308
